Trygg Pharma AS, a company jointly owned by Norwegian biotechnology company Aker BioMarine ASA and New York-based investment fund Lindsay Goldberg, has acquired omega 3 supplier EPAX AS from Austevoll Seafood ASA. As part of the agreement, EPAX has entered a long-term supply agreement with Austral S.A., a subsidiary of Austevoll Seafood. The agreement will ensure continued cooperation between EPAX and Austral and secure supply of crude fish oil from sustainable and traceable sources. Under its new ownership, EPAX will also invest significantly in expanding the capacity of the factory in Aalesund, Norway.